Commentary on "Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery." Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH, Division of Urology, Department of Surgery, University of California San Diego, School of Medicine San Diego, CA. BJU Int 2010;106:1270-6

Stephen Boorjian

doi:10.1016/j.urolonc.2011.07.022

Commentary on "Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery." Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH, Division of Urology, Department of Surgery, University of California San Diego, School of Medicine San Diego, CA. BJU Int 2010;106:1270-6

Stephen Boorjian

Urology

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	586-587
Number of pages	2
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	29
Issue number	5
DOIs	https://doi.org/10.1016/j.urolonc.2011.07.022
State	Published - Sep 2011

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/j.urolonc.2011.07.022

Cite this

Boorjian, S. (2011). Commentary on "Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery." Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH, Division of Urology, Department of Surgery, University of California San Diego, School of Medicine San Diego, CA. BJU Int 2010;106:1270-6. Urologic Oncology: Seminars and Original Investigations, 29(5), 586-587. https://doi.org/10.1016/j.urolonc.2011.07.022

Commentary on "Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery." Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH, Division of Urology, Department of Surgery, University of California San Diego, School of Medicine San Diego, CA. BJU Int 2010;106:1270-6. / Boorjian, Stephen.
In: Urologic Oncology: Seminars and Original Investigations, Vol. 29, No. 5, 09.2011, p. 586-587.

Research output: Contribution to journal › Short survey › peer-review

Boorjian, S 2011, 'Commentary on "Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery." Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH, Division of Urology, Department of Surgery, University of California San Diego, School of Medicine San Diego, CA. BJU Int 2010;106:1270-6', Urologic Oncology: Seminars and Original Investigations, vol. 29, no. 5, pp. 586-587. https://doi.org/10.1016/j.urolonc.2011.07.022

Boorjian S. Commentary on "Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery." Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH, Division of Urology, Department of Surgery, University of California San Diego, School of Medicine San Diego, CA. BJU Int 2010;106:1270-6. Urologic Oncology: Seminars and Original Investigations. 2011 Sep;29(5):586-587. doi: 10.1016/j.urolonc.2011.07.022

Boorjian, Stephen. / Commentary on "Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery." Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH, Division of Urology, Department of Surgery, University of California San Diego, School of Medicine San Diego, CA. BJU Int 2010;106:1270-6. In: Urologic Oncology: Seminars and Original Investigations. 2011 ; Vol. 29, No. 5. pp. 586-587.

@article{de2b9e9dd6364f85afc1fa1f2247957e,

title = "Commentary on {"}Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery.{"} Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH, Division of Urology, Department of Surgery, University of California San Diego, School of Medicine San Diego, CA. BJU Int 2010;106:1270-6",

author = "Stephen Boorjian",

year = "2011",

month = sep,

doi = "10.1016/j.urolonc.2011.07.022",

language = "English (US)",

volume = "29",

pages = "586--587",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Commentary on "Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery." Silberstein JL, Millard F, Mehrazin R, Kopp R, Bazzi W, DiBlasio CJ, Patterson AL, Downs TM, Yunus F, Kane CJ, Derweesh IH, Division of Urology, Department of Surgery, University of California San Diego, School of Medicine San Diego, CA. BJU Int 2010;106:1270-6

AU - Boorjian, Stephen

PY - 2011/9

Y1 - 2011/9

UR - http://www.scopus.com/inward/record.url?scp=80052920388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052920388&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2011.07.022

DO - 10.1016/j.urolonc.2011.07.022

M3 - Short survey

AN - SCOPUS:80052920388

SN - 1078-1439

VL - 29

SP - 586

EP - 587

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 5

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this